Related Experiment Video
Updated: Jun 14, 2026

08:37
Corneal Donor Tissue Preparation for Endothelial Keratoplasty
Published on: June 12, 2012
27.8K
Infectious interface keratitis after Descemet membrane endothelial keratoplasty
Nesrin Tutas Gunaydin1, Burak Tanyıldız1, Baran Kandemir1
1Ophthalmology Department, University of Healty Sciences Dr. Lutf Kırdar Kartal Training and Research Hospital, Istanbul, Turkey.
Arquivos Brasileiros De Oftalmologia
|December 1, 2021
Summary
Infectious interface keratitis (IIK) after Descemet membrane endothelial keratoplasty (DMEK) is challenging. Early surgical intervention improves graft survival and visual acuity in patients unresponsive to medical treatment.
Area of Science:
- Ophthalmology
- Microbiology
- Surgical Science
Background:
- Descemet membrane endothelial keratoplasty (DMEK) is a common procedure for endothelial dysfunction.
- Infectious interface keratitis (IIK) is a rare but serious complication following DMEK.
- Prompt diagnosis and management are crucial for visual outcomes.
Purpose of the Study:
- To evaluate the clinical course and management strategies for infectious interface keratitis (IIK) after Descemet membrane endothelial keratoplasty (DMEK).
Main Methods:
- Retrospective review of 352 DMEK cases.
- Analysis of patients diagnosed with IIK, including microbiological data, onset time, clinical presentation, treatment, and visual outcomes.
- Recorded follow-up duration and interventions such as medical therapy, intrastromal injections, re-DMEK, and penetrating keratoplasty.
Main Results:
- IIK occurred in 8 eyes (2.27%) of 8 patients.
- Common pathogens included three fungal and three bacterial species.
- Median time to infection onset was 164 days; two cases presented early.
- 50% of patients required therapeutic penetrating keratoplasty, and 25% underwent re-DMEK.
- Final corrected distance visual acuity was 20/40 or better in 62.5% of cases.
Conclusions:
- Diagnosing and managing IIK post-DMEK presents significant challenges.
- Early surgical intervention is recommended for cases unresponsive to medical treatment.
- Therapeutic penetrating keratoplasty and re-DMEK can enhance graft survival and visual acuity in IIK patients.

